4.6 Article

Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Oncology

Determining optimal treatment strategy for diffuse glioma: the emerging role of IDH mutations

Tareq A. Juratli et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2015)

Review Medicine, General & Internal

New Developments in the Pathogenesis and Therapeutic Targeting of the IDH1 Mutation in Glioma

Lilia Dimitrov et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2015)

Article Multidisciplinary Sciences

A vaccine targeting mutant IDH1 induces antitumour immunity

Theresa Schumacher et al.

NATURE (2014)

Article Oncology

Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?

Christian Hartmann et al.

CLINICAL CANCER RESEARCH (2011)

Article Clinical Neurology

Monoclonal antibody specific for IDH1 R132H mutation

David Capper et al.

ACTA NEUROPATHOLOGICA (2009)

Article Multidisciplinary Sciences

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Lenny Dang et al.

NATURE (2009)

Article Medicine, General & Internal

IDH1 and IDH2 Mutations in Gliomas

Hai Yan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Clinical Neurology

Analysis of the IDH1 codon 132 mutation in brain tumors

Joerg Balss et al.

ACTA NEUROPATHOLOGICA (2008)